Skip to main content
Equibles
CI logo

CI · Cigna Group · Metrics

Track CI — free

Use CI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$275.28 -0.72 (-0.26%) At close · Sep 18
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$75.22B
Shares
264.24M

CI metrics

83 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$275.28
Market cap
$75.22B

Price action

20 metrics
Price change (1W)
-2.0%
Price change (30D)
-0.8%
Price change (3M)
-1.4%
Price change (6M)
+4.7%
Price change (YTD)
+0.0%
Price change (1Y)
-6.3%
Trailing year
Price change (5Y)
+33.9%
52-week high
$311.00
52-week low
$244.41
Change from 52-week high
-11.5%
Change from 52-week low
+12.6%
Annualized volatility
32.8%
Annualized volatility (3M)
28.4%
Beta
0.2
RSI (14D)
44.3
Price vs SMA 50
-2.7%
Price vs SMA 200
-1.6%
Avg volume (3M)
1.67M
Relative volume
1.4
Average dollar volume
$471.65M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
264.24M

Valuation

12 metrics
P / E (TTM)
11.4
Trailing earnings · reciprocal yield 8.8%
PEG ratio
1.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 375.4%
P / book
1.8
reciprocal yield 56.7%
FCF yield
—
TTM · current market cap
Buyback yield
1.7%
P / FCF
—
P / operating cash flow
7.3
reciprocal yield 13.7%
Earnings yield
8.5%

Historical valuation

8 metrics
P / E historical average (3Y)
18.6×
reciprocal yield 5.4%
P / E historical average (5Y)
16.6×
reciprocal yield 6.0%
EV / revenue historical average (3Y)
0.5×
reciprocal yield 213.5%
EV / revenue historical average (5Y)
0.5×
reciprocal yield 191.6%
EV / EBIT historical average (3Y)
12.0×
reciprocal yield 8.3%
EV / EBIT historical average (5Y)
12.5×
reciprocal yield 8.0%
EV / EBITDA historical average (3Y)
9.0×
reciprocal yield 11.1%
EV / EBITDA historical average (5Y)
9.3×
reciprocal yield 10.7%

Dividends & buybacks

7 metrics
Dividend yield
2.2%
Trailing 12 months
Payout ratio
25.3%
Shareholder yield
3.9%
Dividend / share (TTM)
$6.19
Dividend growth YoY
+4.4%
Dividend growth streak
5
Last ex-dividend
2026-09-08

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
20.6%
Operating margin
3.5%
Trailing 12 months
Net margin
2.3%
Gross profit (TTM)
—
Operating profit (TTM)
$9.96B
Net income (TTM)
$6.42B
Trailing 12 months
Diluted EPS (TTM)
$24.17
FCF margin
—
Effective tax rate
19.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$158.33

Growth

11 metrics
Revenue growth YoY
+6.7%
Year over year
Net income growth YoY
+8.4%
Revenue (TTM)
$282.38B
Trailing 12 months
EPS growth YoY
+10.2%
Shares change YoY
-1.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+15.0%
Revenue CAGR (5Y)
+11.4%
EPS CAGR (3Y)
+1.2%
EPS CAGR (5Y)
-0.7%
FCF CAGR (3Y)
+33.3%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
15.1%
Return on assets
4.1%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
$12.68B
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$6.30B
Total assets
$157.08B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$10.28B
Capital expenditures (TTM)
$1.05B
R&D (TTM)
—
SG&A (TTM)
$14.16B
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
1,705
13F filer change QoQ
+37
Institutional ownership
92.0%

Short interest

3 metrics
Short interest
2.4%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.29M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1739940 CUSIP 125523100 13F (30d) 41 filings 24 filers Visit website Investor relations